Subscribe free

HPB & Spleen ·

Arterial Resection in Pancreatic Cancer: Weighing Feasibility, Morbidity, and Necessity in High-Volume Centers

In the quest for curative pancreatectomy for pancreatic cancer, researchers delve into arterial resection’s (AR) feasibility and outcomes. Analyzing 259 patients, they find AR, despite longer operation times, rivals venous resection in morbidity. Surprisingly, arterial infiltration’s likelihood is questioned, suggesting AR might be replaceable by less invasive techniques. This study at a high-volume pancreatic surgery center challenges the controversy surrounding AR, emphasizing its potential viability with comparable outcomes to venous resection.

Journal Article by Ren L, Jäger C (…) Demir IE et 9 al. in Ann Surg Open

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg Open

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →